A detailed history of Morton Capital Management Llc/Ca transactions in Eli Lilly & CO stock. As of the latest transaction made, Morton Capital Management Llc/Ca holds 418 shares of LLY stock, worth $381,529. This represents 0.09% of its overall portfolio holdings.

Number of Shares
418
Previous 442 5.43%
Holding current value
$381,529
Previous $344 Million 10.06%
% of portfolio
0.09%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$724.87 - $909.04 $17,396 - $21,816
-24 Reduced 5.43%
418 $378 Million
Q1 2024

Apr 12, 2024

BUY
$592.2 - $792.28 $11,844 - $15,845
20 Added 4.74%
442 $344 Million
Q4 2023

Jan 18, 2024

BUY
$525.19 - $619.13 $11,554 - $13,620
22 Added 5.5%
422 $246 Million
Q3 2023

Dec 05, 2023

SELL
$434.7 - $599.3 $16,953 - $23,372
-39 Reduced 8.88%
400 $215 Million
Q2 2023

Dec 05, 2023

BUY
$350.74 - $468.98 $153,974 - $205,882
439 New
439 $206 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $867B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Morton Capital Management Llc/Ca Portfolio

Follow Morton Capital Management Llc/Ca and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morton Capital Management Llc/Ca, based on Form 13F filings with the SEC.

News

Stay updated on Morton Capital Management Llc/Ca with notifications on news.